Why Did Epilepsy/Seizure Focused-Marinus Pharmaceuticals Stock Hit 52-Week Low On Monday?

on MSN ago, source:

Marinus Pharmaceuticals Inc (NASDAQ:MRNS) announced that an independent Data Monitoring Committee (DMC) has recommended ...

Baird Downgrades Marinus Pharmaceuticals (MRNS)

8d ago, source: Hosted on MSN

Marinus Pharmaceuticals Background Information (This description is provided by the company.) Marinus Pharmaceuticals, Inc.

Marinus Pharmaceuticals Inc (MRNS) Shares Rise Despite Market Challenges

3d ago, source: newsheater

In conclusion, Marinus Pharmaceuticals Inc (MRNS) has seen bad performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others rating it as a “hold ...

MRNS Marinus Pharmaceuticals, Inc.

22d ago, source: Seeking Alpha

Marinus Pharmaceuticals, Inc., a pharmaceutical company, focuses on development and commercialization of therapeutic products for patients suffering from rare genetic epilepsies and other seizure ...

Analysts Question Commercial Viability of Marinus' IV Ganaxolone After Interim Analysis Miss

9d ago, source:

Marinus Pharmaceuticals' phase 3 RAISE trial on IV ganaxolone for refractory status epilepticus fails interim analysis.

Marinus faces share-price collapse, weighs 'cost-saving strategies' after IV seizure med comes up short

10d ago, source: FiercePharma

Marinus Pharmaceuticals’ attempt to expand the use of its seizure medicine in a new formulation has hit a pothole. | Marinus ...

Marinus Pharmaceuticals loses 80% of its market value in one day after setback for new drug candidate

10d ago, source:

As a result of the setback, the company said it will implement cost-cutting measures to extend its cash runway beyond the ...

Marinus Pharmaceuticals, Neumora Therapeutics And Other Big Stocks Moving Lower In Monday's Pre-Market Session

10d ago, source:

Marinus Pharmaceuticals, Neumora Therapeutics And Other Big Stocks Moving Lower In Monday's Pre-Market Session U.S. stock ...

Marinus Pharmaceuticals Comments on Patent Challenge by Ovid Therapeutics Inc. and Provides Update on Marinus’ Post Grant Review

29d ago, source: Nasdaq

RADNOR, Pa.--(BUSINESS WIRE)-- Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to developing and commercializing innovative therapeutics to treat seizure disorders ...

Marinus Pharmaceuticals Inc MRNS

7d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Marinus Pharmaceuticals Inc MRNS

8d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Marinus Pharmaceuticals Inc (MRNS)

3d ago, source: Investing

Ampio Pharmaceuticals, Inc. (NYSE:AMPE) has really been popping of late. On Thursday, it was up another 57 cents, or 16%, to 4.19, on 3.55 million shares traded, and looks like it ...